Home » Biotechnology » Continuous Bioprocessing Market

Continuous Bioprocessing Market By Product (Chromatography Systems & Consumables, Bioreactors, Sterilizers, Filtration Systems & Consumables, Centrifuges, Incubators & Shakers, Mixing Systems, Cell Culture Media, Buffers, & Reagents, and Other Instruments and Consumables) By Application (Vaccines, mAb Production, Commercial, Recombinant Protein Production, Cell and Gene Therapy Production, and R&D)– Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Key Highlights of the report

How are the key segments performing in the Continuous Bioprocessing market?

In 2022, the filtration systems and consumables category accounted for a prominent share of the market due to the growing preference for filtration systems in bioprocessing separation techniques.
In 2022, the mAb production segment accounted for a huge share of the market due to growing approvals for therapeutic antibodies and facility expansions for monoclonal antibody manufacturing.
In 2022, the pharmaceutical and biotechnology companies segment held a prominent share in the global continuous bioprocessing market due to the growing focus of regulatory authorities on continuous bioprocessing.

What is the Market Size of Continuous Bioprocessing regarding value?

The global continuous bioprocessing market is anticipated to grow at a substantial CAGR of 22.50% in the upcoming years. The global Continuous Bioprocessing industry was estimated to be worth USD 125.6 million in 2022 and was expected to be worth USD 519.93 million by 2028.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Which region dominated the continuous bioprocessing market?

In 2022, the North American region held a prominent share in the global continuous bioprocessing market due to the increasing burden of chronic diseases, product launches, key strategic initiatives by market players, the establishment of continuous bioprocessing facilities, and technological advancement in the studied market. The study “A Comparative Investment Analysis of Batch Versus Continuous Pharmaceutical Manufacturing Technologies,” published in January 2022, suggested that continuous manufacturing could make oral solid dosage pharmaceuticals more economically attractive in the country than foreign manufacturing of those products. Thus, studies indicating the economic benefits in the US will boost the continuous manufacturing process in the country, which will significantly contribute to market growth.

How is US Market performing in the continuous bioprocessing market?

Rising investments in the studied market will also lead to lucrative market growth in the US. For instance, according to the estimates of the 2022 American Cancer Society, Inc., about 236,740 recent cases of lung cancer will be interpreted in the country in 2022. Furthermore, 79,000 new cases of kidney cancer and 13,920 mortalities will be reported in 2022 from Kidney cancer. The huge burden of cancer is expected to boost the demand for biosimilar and other biopharmaceuticals, thus driving the continuous bioprocessing market.

How is the economy impacting the global continuous bioprocessing growth?

In 2022, the COVID-19 pandemic impacted the economy of the global continuous bioprocessing industry. Changes in the bio/pharmaceutical enterprise have accelerated owing to the ongoing COVID-19 pandemic. The biopharma industry is embracing enhanced strategies to tackle the current pandemic, schedule future pandemics, and decrease supply disruptions. The industry is witnessing collaborations, and partnerships focused on accelerating R&D and implementing rapid, flexible, and modular presentation techniques to speed up the products’ time to market. Such factors are anticipated to drive the demand for continuous bioprocessing amid the COVID-19 pandemic. However, the Ukraine Russia war and rescission will significantly impact the market growth over the forecast period.

What is the competitive environment of the Continuous Bioprocessing market?

The continuous bioprocessing industry’s competitive environment provides information on the entire economic profit made by suppliers and businesses, the sales and revenues created in this sector, the continuous bioprocessing market share globally, the business organization summary, the introduction of new products, and the opportunities for the industrial Continuous Bioprocessing market. For instance, in February 2022, CellulaREvolution raised GBP 1.75 million from a group of notable investors in a round led by Happiness Capital, which will accelerate research & development and strengthen their commercial team as they prepare to launch continuous cell culture technology.

Executive Summary

What are the key trends in the continuous bioprocessing market?

In 2022, the financial assistance provided by the government for research and development activities has increased significantly. Biopharma companies are adopting better strategies to stay competitive in the market.
In February 2020, the US FDA transitioned to a new regulatory pathway to fuel the competition between biological products. The US FDA and the Federal Trade Commission (FTC) signed a joint statement regarding expanded collaboration to help a robust marketplace for biological products such as biosimilars and interchangeable products.

How are COVID-19 pandemic impacted the continuous bioprocessing market?

The COVID-19 pandemic has impacted most industries, including the biopharma industry. Further, with the increasing number of vaccine and therapeutic candidates in the pipeline, the market for novel manufacturing approaches, including continuous processing, is anticipated to impact the long term positively. The industry is transitioning to more flexible and adaptable approaches, necessitating flexible manufacturing methods, such as continuous bioprocessing. This adaptability is helping the rapid development and production of COVID-19 vaccines, diagnostics, equipment, and therapeutics. For instance, a therapeutic agent, monoclonal antibodies, is under investigation to treat COVID-19. In November 2020, the FDA granted emergency use authorization for both bamlanivimab and the combination of basiliximab and imdevimab for use in outpatients with mild to moderate COVID-19 symptoms and a high risk of severe COVID-19 infection. Companies like GlaxoSmithKline Plc. (UK), Sanofi (France) and Johnson & Johnson (US) are exploring different approaches like recombinant protein therapy and viral vector platforms for discovering COVID-19 vaccine modalities.

Which are the key investments by the continuous bioprocessing market players?

Leading players operating in the continuous bioprocessing market are focusing on expanding potassium sulfate production capacities. Apart from this, players are concentrating on strategic mergers and acquisitions, collaborations and creating awareness among farmers via different associations formed to promote smart farming practices to serve more end users in the domestic market to gain a competitive edge. For instance, In January 2022, WuXi Biologics invested EUR 325 million to establish a biomanufacturing facility designed to run continuous bioprocessing.

Some major players in the continuous bioprocessing market are 3M, Thermo Fisher Scientific, Merck KGaA, Sartorius AG, Eppendorf SE, and others.

What are the Key Driving Factors for the Continuous Bioprocessing Market?

The growth of the continuous bioprocessing market is primarily driven by the increased development of novel technologies, rising insistence on biopharmaceuticals, and increased government support for biopharmaceuticals. There has been a considerable escalation in the occurrence of chronic disorders across the world. As per the American Pharmaceutical Review, the insistence for antibody products has escalated, and with the biologic license application, antibody products account for over 65% of all biopharmaceutical products. Additionally, the government has decided to completely favor FDI for the pharmaceutical industry resulting in the rise of collaborations between the government and the pharmaceutical giants.

What are the Major Risks for the Continuous Bioprocessing Market?

The market trends and players for bioprocess technology need help to advance the growth rate. Many governments around the globe have already taken action. Some of these nations are choosing to impose severe regulation policies backed by the high cost of the market instruments preventing the market from expanding during the projected period. As the technology is expensive and the present policies do not support the market, growth will be hampered. The policies laid down by various organizations to supervise the technology are stringent and will harm market growth.

Which is the key application in the Continuous Bioprocessing market?

The contract development and manufacturing and contract research organizations segment are expected to hold a prominent share in the global continuous processing market during the forecast period. Growing investment in contract manufacturing/research and the evolution of CDMOs from batch to continuous manufacturing is expected to drive growth. Pharma and biopharma manufacturers are diverting from batch to continuous processing. This process delivers considerable advantages to manufacturers by being more cost-effective, needing less infrastructure, less space, less investment, and less staff, all while manufacturing products in the same or less time than traditional batch methods.

How is the Continuous Bioprocessing market performing in regions?

Asia Pacific market is anticipated to witness the fastest growth in the global continuous bioprocessing market during the forecast period. The gradually arising landscape of biopharmaceuticals in Asian countries, CDMO developments, expansions in bioprocessing technologies and partnerships, and collaborations among key players for biopharma manufacturing drive the market growth in Asia-Pacific. China and India are among the leading nations in the development and commercialization of biosimilars. The Chinese government delivers numerous initiatives facilitating the development and adoption of biosimilars. The Marketing Authorization Holder (MAH) pilot scheme was established in China, permitting license holders to sell drugs in China using a contract manufacturer, driving innovations and accelerating the speed at which international companies can introduce products in China, facilitating the growth of CDMOs. Such initiatives are driving the adoption of biosimilars globally, thereby positively impacting the demand for continuous bioprocessing technologies.

What is the regulatory landscape for the Continuous Bioprocessing market?

For biotechnology products, enhancing the manufacturing technology behind upstream and downstream processes can reduce product shortages and variability, permit production flexibility, simplify scale-up procedures, enhance product quality, decrease facility footprints, increase productivity, and decrease production costs. Continuous perfusion cell cultures are well established on the upstream side of biotechnology manufacturing. However, truly integrated continuous biomanufacturing needs the uninterrupted connection of constant unit operations (upstream and downstream) with no secret intermediate or hold steps happening between them. This work examines the recent scientific and regulatory landscape surrounding the performance of integrated continuous biomanufacturing.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

What are the key players planning for the future of the Continuous Bioprocessing market?

Growing regional existence and investment in downstream applications are anticipated to deliver a competitive edge in the market. For instance, in March 2021, The United States Pharmacopeia (USP) and Phlow Corp. collaborated to build a new laboratory to develop test methods and standards for continuous manufacturing. This establishment is focused on product development, tech transfer, and drug application filings using continuous manufacturing to foster wider adoption of continuous manufacturing by generic drugs and other pharmaceutical manufacturers.

REPORT ATTRIBUTE	DETAILS
Continuous Bioprocessing Market by Volume	Yes
Continuous Bioprocessing Market by Value	Yes
Continuous Bioprocessing Market, Tornado Analysis	Yes
Continuous Bioprocessing Market, STAR Analysis	Yes
Continuous Bioprocessing Market, SRC Analysis	Yes
Continuous Bioprocessing Market, Import-Export Data	Yes (On Demand)
Continuous Bioprocessing Market Pricing Analysis	Yes (On Demand)
Continuous Bioprocessing Market Segment Analysis	By Product (Chromatography Systems & Consumables, Bioreactors, Sterilizers, Filtration Systems & Consumables, Centrifuges, Incubators & Shakers, Mixing Systems, Cell Culture Media, Buffers, & Reagents, and Other Instruments and Consumables) By Application (Vaccines, mAb Production, Commercial, Recombinant Protein Production, Cell and Gene Therapy Production, and R&D) By End Users (Pharmaceutical and Biotechnology Companies, Contract Development and Manufacturing Organizations, Contract Research Organizations, and Academic and Research Institutes)
Continuous Bioprocessing Market, Regional Analysis	North America (US and Canada) Europe (UK, France, Italy, Germany, Spain, and the Rest of Europe) Asia Pacific (China, Japan, South Korea, India, South East Asia, and the Rest of Asia Pacific) Latin America (Mexico, Brazil, and the Rest of Latin America) Middle East and Africa (South Africa, GCC Countries, and the Rest of the Middle East and Africa)
Continuous Bioprocessing Market Key Companies	3M (US), Cytiva (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Sartorius AG (Germany), Repligen Corporation (US), Eppendorf AG (Germany), Applikon Biotechnology (Netherlands), Pall Corporation (US), and Bionet (Spain).
Continuous Bioprocessing Market Competitive Landscape	Market Share Analysis Competitive Benchmarking Key Players Market Positioning Geographical Presence Analysis Key Strategies Adopted

Segmentation of Global Continuous Bioprocessing Market-

Global Continuous Bioprocessing Market – By Product

Filtration Systems and Consumables
Chromatography Systems and Consumables
Bioreactors
Sterilizers
Centrifuges
Incubators and Shakers
Mixing Systems
Cell Culture Media, Buffers, and Reagents
Other Instruments and Consumables

Global Continuous Bioprocessing Market – By Application

Commercial
Vaccines
mAb production
Recombinant Protein Production
Cell and Gene Therapy Production
R&D

Global Continuous Bioprocessing Market – By End User

Contract Development and Manufacturing Organizations and Contract Research Organizations
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes

Global Continuous Bioprocessing Market – By Region

North America
- US.
- Canada
Europe
- Germany
- France
- UK.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Continuous Bioprocessing Market
2.2. Global Continuous Bioprocessing Market, By Product
2.3. Global Continuous Bioprocessing Market, By Application
2.4. Global Continuous Bioprocessing Market, By End User
2.5. Global Continuous Bioprocessing Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Continuous Bioprocessing Market Value, 2016-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Product
3.5.2. Application
3.5.3. End User
3.5.4. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Continuous Bioprocessing Market
7.1. Global Continuous Bioprocessing Market, by Product, 2016-2030(US$ Bn)
7.1.1. Overview
7.1.2. Global Continuous Bioprocessing Market, By Product, 2022 vs 2030 (in%)
7.1.3. Global Continuous Bioprocessing Market, By Filtration Systems and Consumables, 2016-2030 (US$ Bn)
7.1.4. Global Continuous Bioprocessing Market, By Chromatography Systems and Consumables, 2016-2030 (US$ Bn)
7.1.5. Global Continuous Bioprocessing Market, By Bioreactors, 2016-2030 (US$ Bn)
7.1.6. Global Continuous Bioprocessing Market, By Sterilizers, 2016-2030 (US$ Bn)
7.1.7. Global Continuous Bioprocessing Market, By Centrifuges, 2016-2030 (US$ Bn)
7.1.8. Global Continuous Bioprocessing Market, By Incubators and Shakers, 2016-2030 (US$ Bn)
7.1.9. Global Continuous Bioprocessing Market, By Mixing Systems, 2016-2030 (US$ Bn)
7.1.10. Global Continuous Bioprocessing Market, By Cell Culture Media, Buffers, and Reagents, 2016-2030 (US$ Bn)
7.1.11. Global Continuous Bioprocessing Market, By Other Instruments and Consumables, 2016-2030 (US$ Bn)
7.2. Global Continuous Bioprocessing Market, by Application, 2016-2030(US$ Bn)
7.2.1. Overview
7.2.2. Global Continuous Bioprocessing Market, By Application, 2022 vs 2030 (in%)
7.2.3. Global Continuous Bioprocessing Market, By Commercial, 2016-2030 (US$ Bn)
7.2.4. Global Continuous Bioprocessing Market, By Vaccines, 2016-2030 (US$ Bn)
7.2.5. Global Continuous Bioprocessing Market, By mAb Production, 2016-2030 (US$ Bn)
7.2.6. Global Continuous Bioprocessing Market, By Recombinant Protein Production, 2016-2030 (US$ Bn)
7.2.7. Global Continuous Bioprocessing Market, By Cell and Gene Therapy Production, 2016-2030 (US$ Bn)
7.2.8. Global Continuous Bioprocessing Market, By R&D, 2016-2030 (US$ Bn)
7.3. Global Continuous Bioprocessing Market, by End User, 2016-2030(US$ Bn)
7.3.1. Overview
7.3.2. Global Continuous Bioprocessing Market, By End User, 2022 vs 2030 (in%)
7.3.3. Global Continuous Bioprocessing Market, By Pharmaceutical and Biotechnology Companies, 2016-2030 (US$ Bn)
7.3.4. Global Continuous Bioprocessing Market, By Contract Development and Manufacturing Organizations and Contract Research Organizations, 2016-2030 (US$ Bn)
7.3.5. Global Continuous Bioprocessing Market, By Academic and Research Institutes, 2016-2030 (US$ Bn)

8. North America Continuous Bioprocessing Market Analysis
8.1. North America Continuous Bioprocessing Market, by Product, 2016-2030(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Continuous Bioprocessing Market, by Application, 2016-2030(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Continuous Bioprocessing Market, by End User, 2016-2030(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Continuous Bioprocessing Market, by Country, 2016-2030 (US$ Bn)
8.4.1. U.S.
8.4.1.1. U.S. Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
8.4.1.2. U.S. Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
8.4.1.3. U.S. Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
8.4.1.4. U.S. Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)
8.4.2. Canada
8.4.2.1. Canada Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
8.4.2.2. Canada Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
8.4.2.3. Canada Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
8.4.2.4. Canada Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)

9. Europe Continuous Bioprocessing Market Analysis
9.1. Europe Continuous Bioprocessing Market, by Product, 2016-2030(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Continuous Bioprocessing Market, by Application, 2016-2030(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Continuous Bioprocessing Market, by End User, 2016-2030(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Continuous Bioprocessing Market, by Country, 2016-2030 (US$ Bn)
9.4.1. Germany
9.4.1.1. Germany Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
9.4.1.2. Germany Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
9.4.1.3. Germany Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
9.4.1.4. Germany Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)
9.4.2. France
9.4.2.1. France Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
9.4.2.2. France Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
9.4.2.3. France Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
9.4.2.4. France Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)
9.4.3. UK
9.4.3.1. UK Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
9.4.3.2. UK Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
9.4.3.3. UK Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
9.4.3.4. UK Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)
9.4.4. Italy
9.4.4.1. Italy Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
9.4.4.2. Italy Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
9.4.4.3. Italy Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
9.4.4.4. Italy Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)
9.4.5. Spain
9.4.5.1. Spain Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
9.4.5.2. Spain Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
9.4.5.3. Spain Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
9.4.5.4. Spain Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)
9.4.6. Rest of Europe
9.4.6.1. Rest of Europe Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
9.4.6.2. Rest of Europe Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
9.4.6.3. Rest of Europe Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
9.4.6.4. Rest of Europe Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)

10. Asia Pacific Continuous Bioprocessing Market Analysis
10.1. Asia Pacific Continuous Bioprocessing Market, by Product, 2016-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Continuous Bioprocessing Market, by Application, 2016-2030(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Continuous Bioprocessing Market, by End User, 2016-2030(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Continuous Bioprocessing Market, by Country, 2016-2030 (US$ Bn)
10.4.1. China
10.4.1.1. China Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
10.4.1.2. China Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
10.4.1.3. China Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
10.4.1.4. China Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)
10.4.2. Japan
10.4.2.1. Japan Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
10.4.2.2. Japan Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
10.4.2.3. Japan Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
10.4.2.4. Japan Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)
10.4.3. India
10.4.3.1. India Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
10.4.3.2. India Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
10.4.3.3. India Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
10.4.3.4. India Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)
10.4.4. South Korea
10.4.4.1. South Korea Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
10.4.4.2. South Korea Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
10.4.4.3. South Korea Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
10.4.4.4. South Korea Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)
10.4.5. South-East Asia
10.4.5.1. South-East Asia Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
10.4.5.2. South-East Asia Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
10.4.5.3. South-East Asia Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
10.4.5.4. South-East Asia Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)
10.4.6. Rest of Asia Pacific
10.4.6.1. Rest of Asia Pacific Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
10.4.6.2. Rest of Asia Pacific Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
10.4.6.3. Rest of Asia Pacific Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
10.4.6.4. Rest of Asia Pacific Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)

11. Latin America Continuous Bioprocessing Market Analysis
11.1. Latin America Continuous Bioprocessing Market, by Product, 2016-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Continuous Bioprocessing Market, by Application, 2016-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Continuous Bioprocessing Market, by End User, 2016-2030(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Continuous Bioprocessing Market, by Country, 2016-2030 (US$ Bn)
11.4.1. Brazil
11.4.1.1. Brazil Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
11.4.1.2. Brazil Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
11.4.1.3. Brazil Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
11.4.1.4. Brazil Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)
11.4.2. Mexico
11.4.2.1. Mexico Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
11.4.2.2. Mexico Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
11.4.2.3. Mexico Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
11.4.2.4. Mexico Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)
11.4.3. Rest of Latin America
11.4.3.1. Rest of Latin America Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
11.4.3.2. Rest of Latin America Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
11.4.3.3. Rest of Latin America Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
11.4.3.4. Rest of Latin America Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)

12. Middle East and Africa Continuous Bioprocessing Market Analysis
12.1. Middle East and Africa Continuous Bioprocessing Market, by Product, 2016-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Continuous Bioprocessing Market, by Application, 2016-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Continuous Bioprocessing Market, by End User, 2016-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Continuous Bioprocessing Market, by Country, 2016-2030 (US$ Bn)
12.4.1. GCC Countries
12.4.1.1. GCC Countries il Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
12.4.1.2. GCC Countries Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
12.4.1.3. GCC Countries Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
12.4.1.4. GCC Countries Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)
12.4.2. South Africa
12.4.2.1. South Africa Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
12.4.2.2. South Africa Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
12.4.2.3. South Africa Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
12.4.2.4. South Africa Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)
12.4.3. Rest of Middle East and Africa
12.4.3.1. Rest of Middle East and Africa Continuous Bioprocessing Market Estimates and Forecast, 2016-2030 (US$ Bn)
12.4.3.2. Rest of Middle East and Africa Continuous Bioprocessing, By Product, 2016-2030 (US$ Bn)
12.4.3.3. Rest of Middle East and Africa Continuous Bioprocessing, By Application, 2016-2030 (US$ Bn)
12.4.3.4. Rest of Middle East and Africa Continuous Bioprocessing, By End User, 2016-2030 (US$ Bn)

13. Company Profiles
13.1. 3M (U.S.)
13.1.1. Company Overview
13.1.2. Products/Bioreactors Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2022)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Cytiva (U.S.)
13.3. Thermo Fisher Scientific, Inc. (U.S.)
13.4. Merck KGaA (Germany)
13.5. Sartorius AG (Germany)
13.6. Repligen Corporation (U.S.)
13.7. Eppendorf AG (Germany)
13.8. Applikon Biotechnology (Netherlands)
13.9. Pall Corporation (U.S.)
13.10. Bionet (Spain).
13.11. Others

List of Figures
FIG. 1 Global Continuous Bioprocessing Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Continuous Bioprocessing Market Segmentation
FIG. 4 Global Continuous Bioprocessing Market, by Product, 2022 (US$ Bn)
FIG. 5 Global Continuous Bioprocessing Market, by Application, 2022 (US$ Bn)
FIG. 6 Global Continuous Bioprocessing Market, by End User Type, 2022 (US$ Bn)
FIG. 7 Global Continuous Bioprocessing Market, by Geography, 2022 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Product, 2022
FIG. 9 Attractive Investment Proposition, by Application, 2022
FIG. 10 Attractive Investment Proposition, by End User Type, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key Continuous Bioprocessing Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key Continuous Bioprocessing Market Manufacturers, 2022
FIG. 14 Global Continuous Bioprocessing Market Value Contribution, By Product, 2022 & 2030 (Value %)
FIG. 15 Global Continuous Bioprocessing Market, by Filtration Systems and Consumables, Value, 2016-2030 (US$ Bn)
FIG. 16 Global Continuous Bioprocessing Market, by Chromatography Systems and Consumables, Value, 2016-2030 (US$ Bn)
FIG. 17 Global Continuous Bioprocessing Market, by Bioreactors, Value, 2016-2030 (US$ Bn)
FIG. 18 Global Continuous Bioprocessing Market, by Sterilizers, Value, 2016-2030 (US$ Bn)
FIG. 19 Global Continuous Bioprocessing Market, by Centrifuges, Value, 2016-2030 (US$ Bn)
FIG. 20 Global Continuous Bioprocessing Market, by Incubators and Shakers, Value, 2016-2030 (US$ Bn)
FIG. 21 Global Continuous Bioprocessing Market, by Mixing Systems, Value, 2016-2030 (US$ Bn)
FIG. 22 Global Continuous Bioprocessing Market, by Cell Culture Media, Buffers, and Reagents, Value, 2016-2030 (US$ Bn)
FIG. 23 Global Continuous Bioprocessing Market, by Other Instruments and Consumables, Value, 2016-2030 (US$ Bn)
FIG. 24 Global Continuous Bioprocessing Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 25 Global Continuous Bioprocessing Market, by Commercial, Value, 2016-2030 (US$ Bn)
FIG. 26 Global Continuous Bioprocessing Market, by Vaccines, Value, 2016-2030 (US$ Bn)
FIG. 27 Global Continuous Bioprocessing Market, by mAb Production, Value, 2016-2030 (US$ Bn)
FIG. 28 Global Continuous Bioprocessing Market, by Recombinant Protein Production, Value, 2016-2030 (US$ Bn)
FIG. 29 Global Continuous Bioprocessing Market, by Cell and Gene Therapy Production, Value, 2016-2030 (US$ Bn)
FIG. 30 Global Continuous Bioprocessing Market, by R&D, Value, 2016-2030 (US$ Bn)
FIG. 31 Global Continuous Bioprocessing Market Value Contribution, By End User, 2022 & 2030 (Value %)
FIG. 32 Global Continuous Bioprocessing Market, by Pharmaceutical and Biotechnology Companies, Value, 2016-2030 (US$ Bn)
FIG. 33 Global Continuous Bioprocessing Market, by Contract Development and Manufacturing Organizations and Contract Research Organizations, Value, 2016-2030 (US$ Bn)
FIG. 34 Global Continuous Bioprocessing Market, by Academic and Research Institutes, Value, 2016-2030 (US$ Bn)
FIG. 35 U.S. Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 36 Canada Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 37 Germany Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 38 France Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 39 U.K. Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 40 Italy Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 41 Spain Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 42 Rest of Europe Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 43 China Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 44 Japan Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 45 India Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 46 South Korea Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 47 Southeast Asia Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 48 Rest of Asia Pacific Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 49 Latin America Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 50 Brazil Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 51 Mexico Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 52 Rest of Latin America Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 53 Middle East & Africa Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 54 GCC Countries Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 55 South Africa Continuous Bioprocessing Market, 2016-2030 (US$ Bn)
FIG. 56 Rest of Middle East and Africa Continuous Bioprocessing Market, 2016-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Continuous Bioprocessing Market
TABLE 2 Global Continuous Bioprocessing Market, by Competitive Benchmarking, 2022
TABLE 3 Global Continuous Bioprocessing Market, by Geographical Presence Analysis, 2022
TABLE 4 Global Continuous Bioprocessing Market, by Key Strategies Analysis, 2022
TABLE 5 Global Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 6 Global Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 7 Global Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 8 Global Continuous Bioprocessing Market, by Geography, 2016-2030 (US$ Bn)
TABLE 9 North America Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 10 North America Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 11 North America Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 12 North America Continuous Bioprocessing Market, by Country, 2016-2030 (US$ Bn)
TABLE 13 US Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 14 US Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 15 US Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 16 Canada Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 17 Canada Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 18 Canada Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 19 Europe Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 20 Europe Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 21 Europe Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 22 Europe Continuous Bioprocessing Market, by Country, 2016-2030 (US$ Bn)
TABLE 23 Germany Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 24 Germany Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 25 Germany Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 26 France Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 27 France Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 28 France Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 29 UK Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 30 UK Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 31 UK Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 32 Italy Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 33 Italy Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 34 Italy Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 35 Spain Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 36 Spain Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 37 Spain Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 38 Rest of Europe Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 39 Rest of Europe Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 40 Rest of Europe Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 41 Asia Pacific Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 42 Asia Pacific Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 43 Asia Pacific Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 44 Asia Pacific Continuous Bioprocessing Market, by Country, 2016-2030 (US$ Bn)
TABLE 45 China Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 46 China Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 47 China Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 48 Japan Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 49 Japan Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 50 Japan Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 51 India Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 52 India Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 53 India Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 54 South Korea Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 55 South Korea Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 56 South Korea Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 57 South East Asia Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 58 South East Asia Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 59 South East Asia Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 60 Rest of Asia Pacific Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 61 Rest of Asia Pacific Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 62 Rest of Asia Pacific Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 63 Latin America Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 64 Latin America Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 65 Latin America Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 66 Latin America Continuous Bioprocessing Market, by Country, 2016-2030 (US$ Bn)
TABLE 67 Brazil Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 68 Brazil Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 69 Brazil Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 70 Mexico Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 71 Mexico Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 72 Mexico Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 73 Rest of Latin America Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 74 Rest of Latin America Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 75 Rest of Latin America Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 76 Middle East and Africa Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 77 Middle East and Africa Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 78 Middle East and Africa Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 79 Middle East and Africa Continuous Bioprocessing Market, by Country, 2016-2030 (US$ Bn)
TABLE 80 GCC Countries Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 81 GCC Countries Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 82 GCC Countries Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 83 South Africa Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 84 South Africa Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 85 South Africa Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)
TABLE 86 Rest of Middle East and Africa Continuous Bioprocessing Market, by Product, 2016-2030 (US$ Bn)
TABLE 87 Rest of Middle East and Africa Continuous Bioprocessing Market, by Application, 2016-2030 (US$ Bn)
TABLE 88 Rest of Middle East and Africa Continuous Bioprocessing Market, by End User, 2016-2030 (US$ Bn)

Frequently Asked Questions:

How does COVID-19 Impact the global continuous bioprocessing market?

COVID-19 has had a substantial impact on the market due to the outbreak of the COVID-19 pandemic. The biopharma industry was adopting enhanced strategies to tackle the pandemic, preparing for future pandemics, and minimizing supply disruptions.

Which is the leading region of the market for Continuous Bioprocessing?

North America accounted for the most heightened share in the global continuous bioprocessing market.

What are the key drivers for the growth of the continuous bioprocessing market?

The increasing demand for biopharmaceuticals, technological developments in continuous bioprocessing, product introduction in the area of continuous bioprocessing, and global initiatives helping the adoption of biopharmaceuticals.

Which is the major segment in the continuous bioprocessing market by product?

The filtration systems and consumables segment had a major share in the global market in 2022.

Which is the major segment in the Continuous Bioprocessing market by application?

The mAb production segment had a major share in the global market.

Which is the major segment in the Continuous Bioprocessing market by end-user?

The pharmaceutical and biotechnology companies segment had a major share in the global market.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –